These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10980601)

  • 1. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK.
    Mitchell PJ; Sara EA; Crompton MR
    Oncogene; 2000 Aug; 19(37):4273-82. PubMed ID: 10980601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.
    Ikeda O; Miyasaka Y; Sekine Y; Mizushima A; Muromoto R; Nanbo A; Yoshimura A; Matsuda T
    Biochem Biophys Res Commun; 2009 Jun; 384(1):71-5. PubMed ID: 19393627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Brk SH3 domain in substrate recognition.
    Qiu H; Miller WT
    Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between Brk kinase and insulin receptor substrate-4.
    Qiu H; Zappacosta F; Su W; Annan RS; Miller WT
    Oncogene; 2005 Aug; 24(36):5656-64. PubMed ID: 15870689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours.
    Mitchell PJ; Barker KT; Martindale JE; Kamalati T; Lowe PN; Page MJ; Gusterson BA; Crompton MR
    Oncogene; 1994 Aug; 9(8):2383-90. PubMed ID: 8036022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk.
    Mitchell PJ; Barker KT; Shipley J; Crompton MR
    Oncogene; 1997 Sep; 15(12):1497-502. PubMed ID: 9333026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T; Kujovich J; Reis M; Newman B; Druker BJ
    Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
    Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
    Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells.
    Ikeda O; Mizushima A; Sekine Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
    Cancer Sci; 2011 Apr; 102(4):756-61. PubMed ID: 21205088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
    J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase signalling pathways.
    Pawson T
    Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation.
    Yokouchi M; Suzuki R; Masuhara M; Komiya S; Inoue A; Yoshimura A
    Oncogene; 1997 Jul; 15(1):7-15. PubMed ID: 9233773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and expression of human grap-2, a novel leukocyte-specific SH2- and SH3-containing adaptor-like protein that binds to gab-1.
    Qiu M; Hua S; Agrawal M; Li G; Cai J; Chan E; Zhou H; Luo Y; Liu M
    Biochem Biophys Res Commun; 1998 Dec; 253(2):443-7. PubMed ID: 9878555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
    Kim HIe; Lee ST
    J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
    Lukong KE; Larocque D; Tyner AL; Richard S
    J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1.
    Goel RK; Miah S; Black K; Kalra N; Dai C; Lukong KE
    FEBS J; 2013 Sep; 280(18):4539-59. PubMed ID: 23822091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.
    Ikeda O; Sekine Y; Mizushima A; Nakasuji M; Miyasaka Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
    J Biol Chem; 2010 Dec; 285(49):38093-103. PubMed ID: 20929863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition.
    Qiu H; Miller WT
    J Biol Chem; 2002 Sep; 277(37):34634-41. PubMed ID: 12121988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRK tyrosine kinase expression in a high proportion of human breast carcinomas.
    Barker KT; Jackson LE; Crompton MR
    Oncogene; 1997 Aug; 15(7):799-805. PubMed ID: 9266966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.